These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6401395)

  • 1. Influence of certain prostaglandin synthetase inhibitors on cytoplasmic estrogen receptors in the uterus.
    Sanfilippo JS; Teichman J; Melvin JR; Osyamkpe CO; Wittliff JL
    Am J Obstet Gynecol; 1983 Jan; 145(1):100-4. PubMed ID: 6401395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of prostaglandin synthetase inhibitors on EEG in rat.
    Wallenstein MC
    Eur J Pharmacol; 1985 May; 111(2):201-9. PubMed ID: 3926513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of prostaglandin synthetase inhibitor pretreatment on pentylenetetrazol-induced seizures in rat.
    Wallenstein MC
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):93-104. PubMed ID: 3927864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo.
    Tsang BK; Domingo MT; Spence JE; Garner PR; Dudley DK; Oxorn H
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2081-4. PubMed ID: 3123043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E; von Fischer B
    Adv Prostaglandin Thromboxane Res; 1980; 8():1487-93. PubMed ID: 6769316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of danazol on cytoplasmic and nuclear estrogen binding capacity in the uterus.
    Sanfilippo JS; Teichman J; Melvin JR; Wittliff JL
    Am J Obstet Gynecol; 1983 Oct; 147(4):364-8. PubMed ID: 6684884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-directed synthesis of specific prostaglandins in uterus.
    Ham EA; Cirillo VJ; Zanetti ME; Kuehl FA
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1420-4. PubMed ID: 165507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed.
    Owen PR
    Am J Obstet Gynecol; 1984 Jan; 148(1):96-103. PubMed ID: 6419611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.
    Dawood MY
    Drugs; 1981 Jul; 22(1):42-56. PubMed ID: 6790261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a possible role of prostaglandins in implantation in rats.
    Garg SK; Chaudhury RR
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):299-307. PubMed ID: 6409018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic estrogen treatment causes an alteration in uterine estrogen receptor dynamics of rats.
    Sato B; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
    Biochim Biophys Acta; 1983 Feb; 755(3):412-9. PubMed ID: 6824737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine pressure changes during dysmenorrhea therapy.
    Smith RP; Powell JR
    Am J Obstet Gynecol; 1982 Jun; 143(3):286-92. PubMed ID: 6805330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin synthetase inhibitors antagonize the depressant effects of ethanol.
    George FR; Collins AC
    Pharmacol Biochem Behav; 1979 Jun; 10(6):865-9. PubMed ID: 113788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice.
    Song H; Lim H; Das SK; Paria BC; Dey SK
    Mol Endocrinol; 2000 Aug; 14(8):1147-61. PubMed ID: 10935540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prostaglandin synthetase inhibitors on experimentally induced convulsions in rats.
    Wallenstein MC; Mauss EA
    Pharmacology; 1984; 29(2):85-93. PubMed ID: 6433367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of thrombocyte function by non-steroidal anti-rheumatic agents: a comparative study between diclofenac, acemetacin, mefenamic acid and ibuprofen].
    Raineri-Gerber I; von Felten A
    Schweiz Med Wochenschr; 1991 May; 121(21):783-7. PubMed ID: 1905422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of some prostaglandin synthesis inhibitors on the antinociceptive action of morphine in albino rats.
    Srivastava DN; Bhattacharya SK; Sanyal AK
    Clin Exp Pharmacol Physiol; 1978; 5(5):503-9. PubMed ID: 729208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of inhibition of prostaglandin synthesis in the selection of non-steroidal anti-inflammatory agents.
    Ziel R; Krupp P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):186-91. PubMed ID: 809368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of oxamethacin and sulindac on prostaglandin synthesis].
    Damas J; Volon G
    C R Seances Soc Biol Fil; 1979; 173(4):849-53. PubMed ID: 160831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptor contents of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high- or low-fat diet.
    Noguchi M; Taniya T; Koyasaki N; Kumaki T; Miyazaki I; Mizukami Y
    Cancer Res; 1991 May; 51(10):2683-9. PubMed ID: 1902395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.